[go: up one dir, main page]

WO1994007434A1 - Implant mammaire a enveloppe transparente aux rayonnements - Google Patents

Implant mammaire a enveloppe transparente aux rayonnements Download PDF

Info

Publication number
WO1994007434A1
WO1994007434A1 PCT/US1993/007384 US9307384W WO9407434A1 WO 1994007434 A1 WO1994007434 A1 WO 1994007434A1 US 9307384 W US9307384 W US 9307384W WO 9407434 A1 WO9407434 A1 WO 9407434A1
Authority
WO
WIPO (PCT)
Prior art keywords
shell
radiolucent
breast implant
urethane
polyester urethane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/007384
Other languages
English (en)
Inventor
Terry Russell Knapp
Winston A. Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipomatrix Inc
Original Assignee
Lipomatrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipomatrix Inc filed Critical Lipomatrix Inc
Priority to BR9307139A priority Critical patent/BR9307139A/pt
Priority to EP93919900A priority patent/EP0693910A1/fr
Priority to CA002142996A priority patent/CA2142996C/fr
Priority to AU49983/93A priority patent/AU683223B2/en
Priority to JP6509011A priority patent/JPH09506516A/ja
Publication of WO1994007434A1 publication Critical patent/WO1994007434A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Definitions

  • Breast pros heses are well known in the art and generally include a shell or envelope which is filled with a fluid or gel which desirably is used to enlarge the female breast yet retain its normal appearance, move ⁇ ment, feel, and other cosmetic characteristics.
  • the predominant breast implant had been a sili- cone envelope filled with a silicone gel.
  • re ⁇ cent health concerns have prompted the withdrawal of this implant from the market. These concerns generally relate to the health risks caused by migration of the silicone gel from within the shell, breakage of the shell, or other introduction of the silicone gel into the body.
  • mammograms typically are performed by compressing a breast between two plates which flattens the breast and enables a more uniform exposure. A controlled intensity of x-rays are then passed through the breast for a care- fully controlled time period to image any artifacts in ⁇ dicative of cancer.
  • U.S. Patent No. 4,863,470 discloses a standard breast implant comprised of a silicone shell with a silicone gel fill material.
  • this breast implant construction is well known in the prior art and, up until recently, had been the most popular implant used.
  • this patent discloses an identifica ⁇ tion marker or tab which is made from silicone with bis- muth trioxide or barium sulfate, both of which are much more "radiopaque" than the silicone used for the standard shell or fill material.
  • a marker or tab would remain opaque and thusly visible.
  • This patent also describes a technique used to read this radiopaque marker which is more similar to a chest x-ray than to a mammogram.
  • the patient lies on her back and the x- rays are directed through her breast and chest cavity.
  • energy levels at 125 kVp are common.
  • the intensity of x-rays required for this procedure sub- stantially exceeds that carefully controlled and timed dosage which is used for mammographic procedures.
  • a standard silicone gel and silicone fill material may be radiolucent, it is in reality radiopaque for standard mammographic proce ⁇ dures.
  • the material which the inventors have identified and are contemplating for use for the shell include any one or more of the following: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole- finic elastomers; and styrene-ethylene/butylene-styrene block copolymer. All of these materials have an effec ⁇ tive atomic number of 6.0 within a range of ⁇ 0.5, and therefore exhibit the effective atomic number of fat which is the major component of a human breast.
  • a breast implant which includes a radiolucent shell filled with a radiolu ⁇ cent fill material thereby rendering the entire implant optimally radiolucent for mammographic procedures. It is not believed that a drawing is required or even helpful in understanding the present invention and, hence, none is being submitted.
  • the present invention includes fashioning the shell from any one of a number of materials such as: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole- finic elastomers; and styrene-ethylene/butylene-styrene block copolymer.
  • materials such as: linear aliphatic polyether urethane; linear aliphatic polyester urethane; cyclic aliphatic polyether urethane; cyclic aliphatic polyester urethane; aromatic polyether urethane; aromatic polyester urethane; polybutylene; polypropylene; crosslinked ole- finic elastomers; and styrene-ethylene/butylene-styrene block copolymer.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

Un implant mammaire comprend une enveloppe composée d'une matière choisie dans un groupe de matières présentant une transparence aux rayonnements aux intensités de rayons X généralement utilisées pour des mammographies. L'enveloppe peut être remplie d'une matière de remplissage également transparentes aux rayonnements, conforme à la technique antérieure, afin de constituer un implant mammaire entièrement transparent aux rayonnements. Cet implant améliore la possibilité de détection de tumeurs, par mammographie, chez des patientes ayant reçu de tels implants mammaires, et permet ainsi de diagnostiquer et de traiter plus efficacement le cancer.
PCT/US1993/007384 1992-09-29 1993-08-06 Implant mammaire a enveloppe transparente aux rayonnements Ceased WO1994007434A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BR9307139A BR9307139A (pt) 1992-09-29 1993-08-06 Implante para seios e casca recheada com um material de enchimento compreendida em um implante para seios
EP93919900A EP0693910A1 (fr) 1992-09-29 1993-08-06 Implant mammaire a enveloppe transparente aux rayonnements
CA002142996A CA2142996C (fr) 1992-09-29 1993-08-06 Implant mammaire a enveloppe permeable aux rayons x
AU49983/93A AU683223B2 (en) 1992-09-29 1993-08-06 Breast implant with radiolucent shell
JP6509011A JPH09506516A (ja) 1992-09-29 1993-08-06 放射線透過性包被を有する乳房インプラント

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95268792A 1992-09-29 1992-09-29
US07/952,687 1992-09-29

Publications (1)

Publication Number Publication Date
WO1994007434A1 true WO1994007434A1 (fr) 1994-04-14

Family

ID=25493141

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/007384 Ceased WO1994007434A1 (fr) 1992-09-29 1993-08-06 Implant mammaire a enveloppe transparente aux rayonnements

Country Status (6)

Country Link
EP (1) EP0693910A1 (fr)
JP (1) JPH09506516A (fr)
AU (1) AU683223B2 (fr)
BR (1) BR9307139A (fr)
CA (1) CA2142996C (fr)
WO (1) WO1994007434A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0727232A3 (fr) * 1995-02-14 1996-11-06 Mentor Corp Matériau de remplissage pour prothèses d'implant en tissu mou et implants réalisés avec celui-ci
WO1998010803A1 (fr) * 1996-09-13 1998-03-19 Lipomatrix Incorporated Implant tissulaire expanse et hydraulique
US5941909A (en) * 1995-02-14 1999-08-24 Mentor Corporation Filling material for soft tissue implant prostheses and implants made therewith
US6290723B1 (en) 1994-06-14 2001-09-18 Winston A. Andrews Method of making a synthetic triglyceride filler material

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4995882A (en) * 1989-08-28 1991-02-26 Washington University Radiolucent breast implant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141581A (en) * 1972-10-08 1992-08-25 Markham Harold A Implants with a cover which resists formation of firm spherical encapsulation
US4157085A (en) * 1978-03-24 1979-06-05 Dow Corning Corporation Surgically implantable tissue expanding device and the method of its use
FR2675049A1 (fr) * 1991-04-09 1992-10-16 Mas Jean Claude Prothese mammaire implantable.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4995882A (en) * 1989-08-28 1991-02-26 Washington University Radiolucent breast implant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0693910A4 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290723B1 (en) 1994-06-14 2001-09-18 Winston A. Andrews Method of making a synthetic triglyceride filler material
EP0727232A3 (fr) * 1995-02-14 1996-11-06 Mentor Corp Matériau de remplissage pour prothèses d'implant en tissu mou et implants réalisés avec celui-ci
US5658329A (en) * 1995-02-14 1997-08-19 Mentor Corporation Filling material for soft tissue implant prostheses and implants made therewith
US5941909A (en) * 1995-02-14 1999-08-24 Mentor Corporation Filling material for soft tissue implant prostheses and implants made therewith
EP1382313A1 (fr) * 1995-02-14 2004-01-21 Mentor Corporation Matériau de remplissage pour prothèses d'implant en tissu mou et implants réalisés avec celui-ci
EP1382356A1 (fr) * 1995-02-14 2004-01-21 Mentor Corporation Matériau de remplissage pour prothèses d'implant en tissu mou et implants réalisés avec celui-ci
WO1998010803A1 (fr) * 1996-09-13 1998-03-19 Lipomatrix Incorporated Implant tissulaire expanse et hydraulique

Also Published As

Publication number Publication date
CA2142996A1 (fr) 1994-04-14
JPH09506516A (ja) 1997-06-30
AU683223B2 (en) 1997-11-06
CA2142996C (fr) 2004-03-02
AU4998393A (en) 1994-04-26
EP0693910A4 (fr) 1995-08-03
BR9307139A (pt) 1999-03-30
EP0693910A1 (fr) 1996-01-31

Similar Documents

Publication Publication Date Title
DE3872191T2 (de) Brustprothese mit mehreren kammern.
US4995882A (en) Radiolucent breast implant
EP0521015B1 (fr) Gel bio-osmotique pour protheses d'implant
US8680498B2 (en) Method of utilizing an implant in a human breast
US20060229721A1 (en) Solid implant
Bostwick 3rd et al. Conservative treatment for breast cancer. Complications requiring reconstructive surgery
Schulte et al. Vertebral body replacement with a bioglass-polyurethane composite in spine metastases–clinical, radiological and biomechanical results
Morita et al. Late effects on the eye of conformation radiotherapy for carcinoma of the paranasal sinuses and nasal cavity
Daniels et al. CT recognition of optic nerve sheath meningioma: abnormal sheath visualization.
Sealy et al. Progress in the use of iodine therapy for tumours of the eye
CA2142996C (fr) Implant mammaire a enveloppe permeable aux rayons x
Hamilton et al. The use of gold foil wrapping for radiation protection of the spinal cord for recurrent tumor therapy
Murali et al. Chordoma of the cervical spine
CA2142900A1 (fr) Implant penien rempli de triglyceride
US5653758A (en) Method of using a radiolucent organ displacement device for radiation therapy
Young et al. The relative radiolucencies of breast implant filler materials
Apesos et al. Silicone granuloma following closed capsulotomy of mammary prosthesis
Molteno et al. " Physiological" orbital implant
Camp et al. Radiation necrosis of the calvarium: Report of five cases
Handel et al. An in vivo study of the effect of various breast implant filler materials on mammography
Bret et al. Aneurysmal bone cyst of the cervical spine: report of a case investigated by computed tomographic scanning and treated by a two-stage surgical procedure
Hueston et al. Rupture of subpectoral prostheses during closed compression capsulotomy
Kumar et al. Reversal of visual impairment after interstitial irradiation of pituitary tumor
Pradeep Kumar et al. High‐activity iodine‐125 endocurietherapy for head and neck tumors
Strax Imaging. Follow‐up of breast cancer reconstruction cases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2142996

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993919900

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993919900

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993919900

Country of ref document: EP